fepblue glp 1 2025 GLP-1 Pharmacy Pricing Update (Dec 2025) FEP BLUE Basic Tier Exception

Clinical Update 10/13/2025 MIND Diet for Cognition

In clinical trials, hair loss was directly proportional to the rate and total amount of weight loss in people on the drugs

Novo Nordisk to cut GLP-1 prices in tough US market Novo Nordisk has turned to pricing as a means to shore up its position in the increasingly competitive market for GLP-1 agonist therapies in the US, promising to slash the monthly cost of its semaglutide-based Wegovy weight-loss therapy and Ozempic for type 2 diabetes

By correcting the primary abdominal compression syndromes, the patient experienced a dramatic, rapid resolution of her long-standing abdominal and flank pain

These notes can help your provider to understand if you can make potential lifestyle changes to minimize side effects, or even if you need to potentially change which GLP-1 you administer